MDASI
Showing 26 - 50 of 327
Acute Myeloid Leukemia Trial in Philadelphia (Text Message-Based Navigation Intervention, Behavioral, Psychological or
Recruiting
- Acute Myeloid Leukemia
- Text Message-Based Navigation Intervention
- +3 more
-
Philadelphia, Pennsylvania
- +1 more
Oct 25, 2022
Cancer Trial (device, drug, other)
Not yet recruiting
- Cancer
- Roche DPM Module
- +2 more
- (no location specified)
Jan 19, 2023
Resectable Colorectal Carcinoma, Resectable Digestive System Carcinoma, Resectable Pancreatic Carcinoma Trial in Houston
Active, not recruiting
- Resectable Colorectal Carcinoma
- +2 more
- Acupuncture Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Head and Neck Squamous Cell Carcinoma, Malignant Head and Neck Tumor Trial in Portland (Medical Device Qardio® smart scale Usage
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- Malignant Head and Neck Neoplasm
- Medical Device Qardio® smart scale Usage and Evaluation
- Questionnaire Administration
-
Portland, OregonOHSU Knight Cancer Institute
Jul 11, 2022
Colon Cancer Trial in Nanjing (XLJDOD compound granule, (XLJDOD mimetic agent))
Recruiting
- Colon Cancer
- XLJDOD compound granule
- placebo (XLJDOD mimetic agent)
-
Nanjing, ChinaJiangsu Province Hospital of Traditional Chinese Medicine
Jan 31, 2023
Laryngeal Squamous Cell Carcinoma, Stage II Laryngeal Cancer AJCC v8, Stage III Laryngeal Cancer AJCC v8 Trial in Houston
Recruiting
- Laryngeal Squamous Cell Carcinoma
- +2 more
- Carboplatin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Breast Cancer Female, Leptomeningeal Metastases Trial in Charlottesville (HER2 BATs)
Terminated
- Breast Cancer Female
- Leptomeningeal Metastases
- HER2 BATs
-
Charlottesville, VirginiaUniversity of Virginia
Dec 15, 2022
Hematologic Tumors Trial in Nanjing (virtual reality device)
Recruiting
- Hematologic Neoplasms
- virtual reality device
-
Nanjing, Jiangsu, Chinathe First Affiliated Hospital of Nanjing Medical University
Oct 28, 2022
Retroperitoneal Sarcoma Trial in Houston (Liposomal Bupivacaine, Quadratus Lumborum Block, Questionnaire Administration)
Recruiting
- Retroperitoneal Sarcoma
- Liposomal Bupivacaine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 5, 2022
Glioma Trial in Houston (Questionnaires, Caregiver Assessment)
Not yet recruiting
- Glioma
- Questionnaires
- Caregiver Assessment
-
Houston, TexasM D Anderson Cancer Center
Aug 19, 2022
Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,
Terminated
- Rectal Mucinous Adenocarcinoma
- +8 more
- Capecitabine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Nov 21, 2022
IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal
Terminated
- IDH Family Wildtype
- +2 more
- Laser Interstitial Thermal Therapy
- Lomustine
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Thoracic, Pulmonary Disease Trial in Houston (Gabapentin, Placebo)
Not yet recruiting
- Thoracic
- Pulmonary Disease
- Gabapentin
- Placebo
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Brain Tumor Trial in Houston (tepotinib, tepotinib plus osimertinib)
Not yet recruiting
- Brain Tumor
- tepotinib
- tepotinib plus osimertinib
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Portland (drug, radiation, procedure)
Recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- Pembrolizumab
- +2 more
-
Portland, Oregon
- +1 more
Jan 18, 2023
Recurrent Brain Tumor Trial in Houston (biological, other, radiation)
Active, not recruiting
- Recurrent Brain Neoplasm
- Bevacizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Esophagus Cancer, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (Proton beam therapy, Patient-Reported Outcome
Active, not recruiting
- Esophagus Cancer
- +2 more
- Proton beam therapy
- Patient-Reported Outcome Measures
-
Saint Louis, MissouriWashington University School of Medicine
Aug 10, 2022
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Cancer Fatigue Trial in Houston
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Cognitive Behavior Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 13, 2022
Dehydration, Symptom Cluster, Quality of Life Trial in Miami (CTNSM, Standard of Care Chemotherapy Education)
Recruiting
- Dehydration
- +4 more
- CTNSM
- Standard of Care Chemotherapy Education
-
Miami, FloridaUniversity of Miami Sylvester Comprehensive Cancer Ctr.
Sep 27, 2022
Self-Management, Quality of Life Trial in Pittsburgh (Strong Together serious game, Enhanced Care as Usual)
Recruiting
- Self-Management
- Quality of Life
- Strong Together serious game
- Enhanced Care as Usual
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Aug 22, 2022
Metastatic Malignant Tumor in the Brain, Radiation Therapy Recipient Trial in Houston (behavioral, procedure, other)
Recruiting
- Metastatic Malignant Neoplasm in the Brain
- Radiation Therapy Recipient
- Hand Function Test
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Multiple Myeloma Trial in New York (Acupuncture, Sham acupuncture)
Completed
- Multiple Myeloma
- Acupuncture
- Sham acupuncture
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 13, 2021
Preoperative Walking Evaluation and Postoperative Outcome
Not yet recruiting
- General Surgery
- Perioperative Medicine
- Number of steps recorded by mobile phone as a proxy for physical activity
- (no location specified)
Aug 28, 2023
Pain, Postoperative, Lung Diseases Trial in Milwaukee (Intercostal Nerve Cryoablation, Patient-controlled analgesia (PCA))
Recruiting
- Pain, Postoperative
- Lung Diseases
- Intercostal Nerve Cryoablation
- Patient-controlled analgesia (PCA)
-
Milwaukee, WisconsinThe Medical College of Wisconsin
Jul 11, 2022
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023